Mead Johnson Nutrition CO (MJN) reported quarterly earnings results on Thursday, Apr-28-2016. The company said it had a profit of $0.87 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.03. Analysts had a consensus of $0.84. The company posted revenue of $962.10 million in the period, compared to analysts expectations of $954.99 million. The company’s revenue was down -12.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.09 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. Mead Johnson Nutrition CO was Upgraded by Credit Suisse to ” Outperform” on Mar 16, 2016.
Mead Johnson Nutrition CO opened for trading at $84.47 and hit $85.36 on the upside on Wednesday, eventually ending the session at $84.93, with a gain of 0.74% or 0.62 points. The heightened volatility saw the trading volume jump to 21,27,527 shares. Company has a market cap of $15,836 M.
In a different news, on Dec 14, 2015, Michel Martinus Gerardus Cup (CFO) purchased 4,000 shares at $76.50 per share price. According to the SEC, on Nov 25, 2015, Robert S Singer (director) sold 4,000 shares at $81.77 per share price. On Sep 15, 2015, Clesteen A Clark (director) purchased 500 shares at $76.05 per share price, according to the Form-4 filing with the securities and exchange commission.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.